Becton, Dickinson and Company Logo

Becton, Dickinson and Company

0R19.L

(0.0)
Stock Price

226,50 USD

6.69% ROA

5.51% ROE

48.39x PER

Market Cap.

68.176.336.540,00 USD

74.7% DER

1.61% Yield

7.13% NPM

Becton, Dickinson and Company Stock Analysis

Becton, Dickinson and Company Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Becton, Dickinson and Company Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Becton, Dickinson and Company Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Becton, Dickinson and Company Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Becton, Dickinson and Company Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Becton, Dickinson and Company Revenue
Year Revenue Growth
2013 8.054.000.000
2014 8.446.000.000 4.64%
2015 10.282.000.000 17.86%
2016 12.483.000.000 17.63%
2017 12.093.000.000 -3.23%
2018 15.983.000.000 24.34%
2019 16.218.000.000 1.45%
2020 16.074.000.000 -0.9%
2021 19.131.000.000 15.98%
2022 18.870.000.000 -1.38%
2023 19.372.000.000 2.59%
2024 19.960.000.000 2.95%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Becton, Dickinson and Company Research and Development Expenses
Year Research and Development Expenses Growth
2013 494.000.000
2014 550.000.000 10.18%
2015 632.000.000 12.97%
2016 828.000.000 23.67%
2017 774.000.000 -6.98%
2018 1.004.000.000 22.91%
2019 1.004.000.000 0%
2020 1.039.000.000 3.37%
2021 1.279.000.000 18.76%
2022 1.256.000.000 -1.83%
2023 1.237.000.000 -1.54%
2024 1.196.000.000 -3.43%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Becton, Dickinson and Company General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 0
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Becton, Dickinson and Company EBITDA
Year EBITDA Growth
2013 2.126.000.000
2014 2.153.000.000 1.25%
2015 2.684.000.000 19.78%
2016 3.208.000.000 16.33%
2017 3.108.000.000 -3.22%
2018 4.104.000.000 24.27%
2019 4.562.000.000 10.04%
2020 3.728.000.000 -22.37%
2021 4.724.000.000 21.08%
2022 4.614.000.000 -2.38%
2023 5.039.000.000 8.43%
2024 5.292.000.000 4.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Becton, Dickinson and Company Gross Profit
Year Gross Profit Growth
2013 4.171.000.000
2014 4.301.000.000 3.02%
2015 4.988.000.000 13.77%
2016 5.991.000.000 16.74%
2017 5.942.000.000 -0.82%
2018 7.269.000.000 18.26%
2019 7.498.000.000 3.05%
2020 6.798.000.000 -10.3%
2021 8.631.000.000 21.24%
2022 8.477.000.000 -1.82%
2023 8.823.000.000 3.92%
2024 9.228.000.000 4.39%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Becton, Dickinson and Company Net Profit
Year Net Profit Growth
2013 929.000.000
2014 1.185.000.000 21.6%
2015 695.000.000 -70.5%
2016 976.000.000 28.79%
2017 1.100.000.000 11.27%
2018 311.000.000 -253.7%
2019 1.233.000.000 74.78%
2020 874.000.000 -41.08%
2021 2.092.000.000 58.22%
2022 1.779.000.000 -17.59%
2023 1.470.000.000 -21.02%
2024 1.948.000.000 24.54%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Becton, Dickinson and Company Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 5
2014 6 20%
2015 3 -66.67%
2016 5 25%
2017 5 20%
2018 1 -400%
2019 4 75%
2020 3 -100%
2021 7 66.67%
2022 6 -20%
2023 5 0%
2024 7 16.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Becton, Dickinson and Company Free Cashflow
Year Free Cashflow Growth
2013 983.000.000
2014 1.154.000.000 14.82%
2015 1.134.000.000 -1.76%
2016 1.841.000.000 38.4%
2017 1.823.000.000 -0.99%
2018 1.970.000.000 7.46%
2019 2.373.000.000 16.98%
2020 2.729.000.000 13.05%
2021 3.453.000.000 20.97%
2022 1.661.000.000 -107.89%
2023 2.115.000.000 21.47%
2024 1.086.000.000 -94.75%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Becton, Dickinson and Company Operating Cashflow
Year Operating Cashflow Growth
2013 1.505.000.000
2014 1.746.000.000 13.8%
2015 1.730.000.000 -0.92%
2016 2.559.000.000 32.4%
2017 2.550.000.000 -0.35%
2018 2.865.000.000 10.99%
2019 3.330.000.000 13.96%
2020 3.539.000.000 5.91%
2021 4.647.000.000 23.84%
2022 2.634.000.000 -76.42%
2023 2.989.000.000 11.88%
2024 1.265.000.000 -136.28%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Becton, Dickinson and Company Capital Expenditure
Year Capital Expenditure Growth
2013 522.000.000
2014 592.000.000 11.82%
2015 596.000.000 0.67%
2016 718.000.000 16.99%
2017 727.000.000 1.24%
2018 895.000.000 18.77%
2019 957.000.000 6.48%
2020 810.000.000 -18.15%
2021 1.194.000.000 32.16%
2022 973.000.000 -22.71%
2023 874.000.000 -11.33%
2024 179.000.000 -388.27%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Becton, Dickinson and Company Equity
Year Equity Growth
2013 5.043.000.000
2014 5.053.000.000 0.2%
2015 7.164.000.000 29.47%
2016 7.633.000.000 6.14%
2017 12.948.000.000 41.05%
2018 20.994.000.000 38.33%
2019 21.081.000.000 0.41%
2020 23.765.000.000 11.29%
2021 23.677.000.000 -0.37%
2022 25.282.000.000 6.35%
2023 25.796.000.000 1.99%
2024 25.868.000.000 0.28%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Becton, Dickinson and Company Assets
Year Assets Growth
2013 12.149.000.000
2014 12.447.000.000 2.39%
2015 26.478.000.000 52.99%
2016 25.586.000.000 -3.49%
2017 37.734.000.000 32.19%
2018 53.904.000.000 30%
2019 51.765.000.000 -4.13%
2020 54.012.000.000 4.16%
2021 53.866.000.000 -0.27%
2022 52.934.000.000 -1.76%
2023 52.780.000.000 -0.29%
2024 55.582.000.000 5.04%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Becton, Dickinson and Company Liabilities
Year Liabilities Growth
2013 7.106.000.000
2014 7.394.000.000 3.9%
2015 19.314.000.000 61.72%
2016 17.953.000.000 -7.58%
2017 24.786.000.000 27.57%
2018 32.910.000.000 24.69%
2019 30.684.000.000 -7.25%
2020 30.247.000.000 -1.44%
2021 30.189.000.000 -0.19%
2022 27.652.000.000 -9.17%
2023 26.984.000.000 -2.48%
2024 29.714.000.000 9.19%

Becton, Dickinson and Company Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
68.4
Net Income per Share
4.87
Price to Earning Ratio
48.39x
Price To Sales Ratio
3.44x
POCF Ratio
17.33
PFCF Ratio
21.16
Price to Book Ratio
2.64
EV to Sales
4.19
EV Over EBITDA
17.49
EV to Operating CashFlow
21.05
EV to FreeCashFlow
25.77
Earnings Yield
0.02
FreeCashFlow Yield
0.05
Market Cap
68,18 Bil.
Enterprise Value
83,04 Bil.
Graham Number
98.93
Graham NetNet
-71.85

Income Statement Metrics

Net Income per Share
4.87
Income Quality
2.7
ROE
0.06
Return On Assets
0.03
Return On Capital Employed
0.05
Net Income per EBT
0.84
EBT Per Ebit
0.65
Ebit per Revenue
0.13
Effective Tax Rate
0.13

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.42
Operating Profit Margin
0.13
Pretax Profit Margin
0.08
Net Profit Margin
0.07

Dividends

Dividend Yield
0.02
Dividend Yield %
1.61
Payout Ratio
0.77
Dividend Per Share
3.8

Operating Metrics

Operating Cashflow per Share
13.61
Free CashFlow per Share
11.11
Capex to Operating CashFlow
0.18
Capex to Revenue
0.04
Capex to Depreciation
0.33
Return on Invested Capital
0.05
Return on Tangible Assets
0.07
Days Sales Outstanding
47.79
Days Payables Outstanding
157.7
Days of Inventory on Hand
103.44
Receivables Turnover
7.64
Payables Turnover
2.31
Inventory Turnover
3.53
Capex per Share
2.49

Balance Sheet

Cash per Share
18,32
Book Value per Share
89,24
Tangible Book Value per Share
-29.63
Shareholders Equity per Share
89.24
Interest Debt per Share
68.34
Debt to Equity
0.75
Debt to Assets
0.35
Net Debt to EBITDA
3.13
Current Ratio
1.85
Tangible Asset Value
-8,59 Bil.
Net Current Asset Value
-17,51 Bil.
Invested Capital
46576000000
Working Capital
5,60 Bil.
Intangibles to Total Assets
0.62
Average Receivables
2,58 Bil.
Average Payables
4,92 Bil.
Average Inventory
3242500000
Debt to Market Cap
0.28

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Becton, Dickinson and Company Dividends
Year Dividends Growth
2016 1
2017 3 100%
2018 2 -100%
2022 7 83.33%
2023 4 -100%
2024 3 -50%

Becton, Dickinson and Company Profile

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

CEO
Mr. Thomas E. Polen Jr.
Employee
70.000
Address
1 Becton Drive
Franklin Lakes, 07417-1880

Becton, Dickinson and Company Executives & BODs

Becton, Dickinson and Company Executives & BODs
# Name Age
1 Mr. Thomas E. Polen Jr.
President, Chief Executive Officer & Chairman
70
2 Mr. Thomas J. Spoerel
Senior Vice President, Controller & Chief Accounting Officer
70
3 Mr. Greg Rodetis
Head of Investor Relations
70
4 Ms. Michelle Quinn
Executive Vice President & General Counsel
70
5 Mr. Christopher J. DelOrefice
Executive Vice President & Chief Financial Officer
70
6 Ms. Shana Carol Neal
Executive Vice President & Chief People Officer
70
7 Mr. Michael Garrison
Executive Vice President & President of Medical segment
70
8 Ms. Elizabeth McCombs
Executive Vice President & Chief Technology Officer
70
9 Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.
Senior Vice President, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
70
10 Ms. Denise Russell Fleming
Executive Vice President of Technology & Global Services and Chief Information Officer
70

Becton, Dickinson and Company Competitors

Zoetis Inc. Logo
Zoetis Inc.

0M3Q.L

(0.0)
Lowe's Companies, Inc. Logo
Lowe's Companies, Inc.

0JVQ.L

(0.0)
Prologis, Inc. Logo
Prologis, Inc.

0KOD.L

(0.0)
Accenture plc Logo
Accenture plc

0Y0Y.L

(0.0)
Eaton Corporation plc Logo
Eaton Corporation plc

0Y3K.L

(0.2)